Navigation Links
Genos receives CAP Accreditation for Meeting the Highest Standards in Laboratory Practices
Date:2/16/2017

SAN FRANCISCO, Feb. 16, 2017 /PRNewswire/ -- Genos, a community for personal genetic discovery and research, today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP). The CAP Accreditation is presented to laboratories that meet stringent requirements around quality, accuracy and consistency and who demonstrate scientifically rigorous processes.

"Genos is committed to maintaining the highest standards of excellence in laboratory practices. We're honored to be receiving CAP accreditation," said Jill MacAfee, CLS, Director of Laboratory Operations at Genos.

"The CAP accreditation helps demonstrate Genos' commitment to the quality and the accuracy of its data for purposes of its Impact Network that connects researchers with high-quality genomic and phenotypic data," said Arthur Baca, M.D., Ph.D., Laboratory Director of Genos. "With this accomplishment under its belt, Genos will continue to grow its community of sequenced individuals and enable acceleration of research initiatives."

Genos' platform launched in December 2016 to offer exome sequencing and empower individuals to participate in groundbreaking research projects on their own terms through the Impact Network. The initial set of research partners include, NantBioScience, NantKwest, Broad Institute, and the Utah Foundation for Biomedical Research.

About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit cap.org

About Genos
Genos is a crowdsourcing platform for genomics research and discovery. The company's mission is to break down the barriers to accelerate disease research and medical cures. The Genos community democratizes access to comprehensive personal discovery through DNA, and empowers individuals to retain ownership of their genetic data and consent in the research process. Genos is backed by strategic investors with deep roots in healthcare and technology, and the company's advisors include luminaries in genetics, economics, and consumer technology. For more information, or to help crowdsource cures on your terms, please visit www.genos.co.

Media Contacts

McKenzie Haggard
Method Communications
(801) 461-9773
mckenzie@methodcommunications.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genos-receives-cap-accreditation-for-meeting-the-highest-standards-in-laboratory-practices-300408537.html


'/>"/>
SOURCE Genos
Copyright©2017 PR Newswire.
All rights reserved


Related biology news :

1. Carnegies Chris Field receives Max Planck Research Prize
2. VCU receives NIH grant to examine the biology of allergic disease
3. Wayne State receives NSF grant to develop plan for field-based water research center
4. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
5. International Rett Syndrome Foundation chief science officer receives prestigious military awards
6. Wayne State receives grant to reduce emissions of toxins by power plants into Great Lakes
7. UCSF receives $4.5M to study value of gene sequencing in newborns
8. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
9. Garvan Institute receives grant to research role of long non-coding RNAs in Parkinsons disease
10. SOFIE BIO Receives $1.8M Phase II SBIR Grant
11. AgriLife researcher Xiuren Zhang receives National Science Foundation CAREER grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... February 28, 2017 , ... RoviSys, a ... today that it has joined the Cisco® Digital Solutions Integrator Program. As a ... hardware and software that addresses Industrial IT and Business IT in manufacturing environments. ...
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ... millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. , ... express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody ...
(Date:2/28/2017)... and PHILADELPHIA , Feb. 28, 2017 ... held biopharmaceutical company focusing on debilitating diseases including rare ... announced that the company joins with the National Organization ... advocacy and support around the world in commemorating Rare ... unique challenges and needs of the millions of patients ...
Breaking Biology Technology: